Histological and Immunocytochemical Analysis of Acne

Janaki Madhuri^*
*Correspondence: Janaki Madhuri, Department of Dermatology, General Infirmary, Leeds, UK, Email:

Keywords

Acne • Histological analysis • Immunocytochemistry • Sebaceous glands

Introduction

Acne vulgaris ranks among the most prevalent inflammatory dermatological conditions, affecting individuals regardless of gender or ethnicity. A significant number of patients with inflammatory acne experience disfiguring scarring, presenting a formidable challenge in terms of treatment. The pathogenesis of acne is believed to involve a cell-mediated immune response, albeit its magnitude varies among patients [1].

In the United States alone, over 45 million individuals contend with acne vulgaris, a pilosebaceous follicle-related cutaneous disorder. The development of acne is a complex interplay of factors, encompassing abnormal hyperkeratinization, heightened sebum production, hormonal influences, cutaneous microbial activity and immunological processes. Notably, several of the immunological mechanisms contributing to the formation of acne lesions occur directly within the skin itself. The skin assumes a pivotal role in the innate immune system, featuring both physical barriers and rapid cellular responses orchestrated by keratinocytes, Langerhans cells and various infiltrating inflammatory cells [2].

Description

The microcomedone represents the initial subclinical acne lesion, characterized by heightened follicular epithelial proliferation. Inflammatory cells have been detected on the periphery of these lesions. This study aimed to elucidate whether inflammatory processes precede or succeed hyperproliferative changes. Immunohistochemical techniques were employed to investigate cellular, vascular and proliferative markers in biopsies obtained from clinically normal follicles in unaffected skin and early-stage inflamed acne lesions. Control follicles were sourced from individuals without acne, exhibiting no microcomedonal attributes [3,4]. Notably, follicles in unaffected skin exhibited an absence of microcomedonal features, raising intriguing questions about the onset of inflammation in acne pathogenesis.

Acne, a common contributor to Post-Inflammatory Hyperpigmentation (PIH), especially among individuals with varied skin tones, often poses greater distress to patients than the acne itself. Topical retinoids, approved for acne treatment, as well as pigmentation disorders like melasma and photo damage-induced mottled hyperpigmentation, have demonstrated efficacy in reducing hyperpigmentation in patients with skin of color. Consequently, initiating treatment with topical retinoids at the earliest opportunity, unless contraindicated, is advisable. Strategies such as employing innovative formulations or applying recommended moisturizers can help mitigate irritation. Furthermore, combining retinoids with other topical agents and procedures like superficial chemical peels can enhance the management of hyperpigmentation. It's worth noting that primary acne lesions typically improve weeks ahead of the resolution of PIH, emphasizing the importance of managing patient expectations to reduce frustration. Additionally, increased education for healthcare providers and researchers regarding the presentation and management of dermatologic conditions in SOC patients is warranted [5].

Conclusion

Recent insights emphasize the critical involvement of cellular inflammatory processes in every facet of acne lesion evolution, spanning from the preclinical inception to the clinical manifestation of active lesions and their eventual resolution. Acne has undergone a transformative paradigm shift, transitioning from primarily a hyperproliferative disorder of the sebaceous follicle to a fundamentally inflammatory skin condition. While the sequence of events leading to lesion formation is becoming more discernible, the precise triggers that initiate this process remain enigmatic. Addressing this challenge requires the development of noninvasive techniques capable of identifying preclinical "acneprone" follicles. Furthermore, disparities in the inflammatory profiles between inflamed lesions in individuals with scarring acne and those without scarring acne underscore the multifaceted nature of acne as a disorder encompassing diverse pathological mechanisms.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Tuchayi, Sara Moradi, Evgenia Makrantonaki, Ruta Ganceviciene and Clio Dessinioti, et al. "Acne vulgaris." Nat Rev Dis Primers 1 (2015):1-20.

Google Scholar, Crossref, Indexed at

2. Saurat, Jean-Hilaire. "Strategic targets in acne: The comedone switch in question." Derm 276 (2015):105-111.

Google Scholar, Crossref, Indexed at

3. Cunliffe, William J., Holland D.B and Jeremy A. "Comedone formation: Etiology, clinical presentation and treatment." Clin Dermatol 22 (2004):367-374.

Google Scholar, Crossref, Indexed at

4. Do, Thy Thy, Semyon Zarkhin, Jeffrey S. Orringer and Shari Nemeth, et al. "Computer-assisted alignment and tracking of acne lesions indicate that most inflammatory lesions arise from comedones and de novo." J Am Acad Dermatol 58 (2008): 603-608.

Google Scholar, Crossref, Indexed at

5. Norris, J.F.B. and Cunliffe W.J. "A histological and immunocytochemical study of early acne lesions." Br J Dermatol 118 (1988): 651-659.

Google Scholar, Crossref, Indexed at